Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -101,875 | -12,094 | -2,695 | -3,707 | -9,843 |
| Depreciation Amortization | 256 | 1 | 14 | 18 | 21 |
| Accounts receivable | -352 | N/A | -69 | 431 | -144 |
| Accounts payable and accrued liabilities | 1,002 | 281 | 197 | -326 | -1,010 |
| Other Working Capital | 1,066 | -51 | 140 | 105 | -1,155 |
| Other Operating Activity | 71,710 | 6,781 | -250 | -1,135 | 5,520 |
| Operating Cash Flow | $-28,193 | $-5,082 | $-2,663 | $-4,613 | $-6,612 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 108 | 3,958 | 3,883 |
| PPE Investments | -183 | -10 | 49 | 8 | 5 |
| Net Acquisitions | 13,646 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $13,463 | $-10 | $157 | $3,967 | $3,888 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 14,871 | N/A | N/A | N/A | N/A |
| Debt Repayment | -898 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 7,344 | 1,346 | N/A | 55 | N/A |
| Other Financing Activity | -329 | 4,338 | 0 | 0 | 0 |
| Financing Cash Flow | $20,988 | $5,684 | $N/A | $55 | $N/A |
| Exchange Rate Effect | -7 | N/A | 16 | -22 | 52 |
| Beginning Cash Position | 594 | 2 | 3,617 | 4,231 | 6,902 |
| End Cash Position | 6,845 | 594 | 1,126 | 3,617 | 4,231 |
| Net Cash Flow | $6,251 | $592 | $-2,491 | $-613 | $-2,671 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,193 | -5,082 | -2,663 | -4,613 | -6,612 |
| Capital Expenditure | -183 | -10 | -2 | -28 | -4 |
| Free Cash Flow | -28,376 | -5,092 | -2,665 | -4,641 | -6,616 |